PD-L1 Expressions in Non-small Cell Lung Cancer and its Correlation with Imaging Findings

被引:0
|
作者
Shigeta, N. [1 ]
Adachi, H. [1 ]
Ito, H. [1 ]
Isaka, T. [1 ]
Murakami, K. [1 ]
Miura, J. [1 ]
Kikunishi, N. [1 ]
Saito, H. [1 ]
Yokose, T. [1 ]
机构
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
关键词
non-small cell lung cancer; PD-L1; imaging features;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP06.02-03
引用
收藏
页码:S480 / S480
页数:1
相关论文
共 50 条
  • [31] PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
    Grigg, Claud
    Rizvi, Naiyer A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [32] The role of PD-L1 in EGFR-mutant non-small cell lung cancer
    Gao, Wentao
    Wang, Lingling
    Zhao, Yanyan
    Zhu, Lucheng
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [33] MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    Kim, Eun Young
    Kim, Arum
    Kim, Se Kyu
    Chang, Yoon Soo
    LUNG CANCER, 2017, 110 : 63 - 67
  • [34] PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer
    Smit, Jasper
    Borm, Frank J.
    Niemeijer, Anna-Larissa N.
    Huisman, Marc C.
    Hoekstra, Otto S.
    Boellaard, Ronald
    Oprea-Lager, Daniela E.
    Vugts, Danielle J.
    van Dongen, Guus A. M. S.
    de Wit-van der Veen, Berlinda J.
    Thunnissen, Erik
    Smit, Egbert F.
    de Langen, Adrianus J.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) : 686 - 693
  • [35] Relationship Between PD-L1 Expression and FDG-PET Imaging in Non-Small Cell Lung Cancer
    Onodera, K.
    Ueda, K.
    Hasumi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S412 - S412
  • [36] What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?
    Bravaccini, Sara
    LUNG CANCER, 2019, 132 : 152 - 153
  • [37] Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β
    Hirayama, Aiko
    Tanaka, Kentaro
    Tsutsumi, Hirono
    Nakanishi, Takayuki
    Yamashita, Sho
    Mizusaki, Shun
    Ishii, Yumiko
    Ota, Keiichi
    Yoneshima, Yasuto
    Iwama, Eiji
    Okamoto, Isamu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer
    Zhang, Shuling
    Bai, Xueli
    Shan, Fengping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [39] Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations
    Dantoing, Edouard
    Piton, Nicolas
    Salaun, Mathieu
    Thiberville, Luc
    Guisier, Florian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [40] Expression analysis of programmed cell death 1 ligand 1 (PD-L1) in patients with non-small cell lung cancer
    Peng, Nanqiu
    Qin, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (01): : 1 - 5